Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity
- PMID: 10348825
- DOI: 10.1016/s0016-5085(99)70506-8
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity
Abstract
Background & aims: The spectrum of nonalcoholic fatty liver disease ranges from fatty liver alone to nonalcoholic steatohepatitis. Most previous studies have short follow-up and have not carefully delineated different histological types when determining clinical outcomes. The aim of this study was to compare clinical characteristics and outcomes of patients with different types of nonalcoholic fatty liver.
Methods: All liver biopsy specimens from 1979 to 1987 with fat accumulation were assessed for inflammation, ballooning degeneration, Mallory hyaline, and fibrosis. Biopsy specimens were also assessed for histological iron and hepatitis C RNA. Outcomes were cirrhosis, mortality, and liver-related mortality.
Results: Of 772 liver biopsy specimens, complete data were available in 132 patients. Fatty liver (type 1) did not differ from the other three types combined with respect to gender, race, age, or obesity. Cirrhosis was more common in the other types combined (22%) than fatty liver alone (4%; P </= 0.001). Overall mortality, histological iron, and hepatitis C did not differ between groups. Most of the liver-related deaths were in type 4.
Conclusions: The outcome of cirrhosis and liver-related death is not uniform across the spectrum of nonalcoholic fatty liver. These poor outcomes are more frequent in patients in whom biopsies show ballooning degeneration and Mallory hyaline or fibrosis.
Similar articles
-
Hepatic iron and nonalcoholic fatty liver disease.Hepatology. 1999 Oct;30(4):847-50. doi: 10.1002/hep.510300407. Hepatology. 1999. PMID: 10498632
-
Pathologic features associated with fibrosis in nonalcoholic fatty liver disease.Hum Pathol. 2004 Feb;35(2):196-9. doi: 10.1016/j.humpath.2003.09.018. Hum Pathol. 2004. PMID: 14991537
-
The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years.Hepatology. 1990 Jan;11(1):74-80. doi: 10.1002/hep.1840110114. Hepatology. 1990. PMID: 2295475
-
[Nonalcoholic steatohepatitis: a brief review on its concept].Nihon Rinsho. 2006 Jun;64(6):1021-4. Nihon Rinsho. 2006. PMID: 16768104 Review. Japanese.
-
Wilson disease - liver pathology.Handb Clin Neurol. 2017;142:71-75. doi: 10.1016/B978-0-444-63625-6.00007-0. Handb Clin Neurol. 2017. PMID: 28433112 Review.
Cited by
-
Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease.Hepatology. 2017 Jan;65(1):65-77. doi: 10.1002/hep.28776. Epub 2016 Oct 12. Hepatology. 2017. PMID: 27532276 Free PMC article.
-
Hard clinical outcomes in patients with NAFLD.Hepatol Int. 2013 Dec;7 Suppl 2:790-9. doi: 10.1007/s12072-013-9455-y. Epub 2013 Aug 6. Hepatol Int. 2013. PMID: 26202293
-
Epidemiology of hepatocellular carcinoma: consider the population.J Clin Gastroenterol. 2013 Jul;47 Suppl(0):S2-6. doi: 10.1097/MCG.0b013e3182872f29. J Clin Gastroenterol. 2013. PMID: 23632345 Free PMC article. Review.
-
Non-alcoholic fatty liver disease: the pathologist's perspective.Clin Mol Hepatol. 2023 Feb;29(Suppl):S302-S318. doi: 10.3350/cmh.2022.0329. Epub 2022 Nov 15. Clin Mol Hepatol. 2023. PMID: 36384146 Free PMC article. Review.
-
NAFLD and NASH in Postmenopausal Women: Implications for Diagnosis and Treatment.Endocrinology. 2020 Oct 1;161(10):bqaa134. doi: 10.1210/endocr/bqaa134. Endocrinology. 2020. PMID: 32776116 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical